Developer docs
API playgroundTry for free, no card

Search company profiles

ValGenesis

Full company profile

uuid0000cu1

Namestring
ValGenesis
Legal namestring
ValGenesis, Inc.
Websiteurl
valgenesis.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

ValGenesis is a privately held, AI-enabled digital validation lifecycle management company founded in 2005 and headquartered in the San Jose, California area. The company sells an integrated platform called Smart GxP™ to pharmaceutical, biotechnology, medical device, and contract development and manufacturing organizations (CDMOs), reporting that 30 of the top 50 global life sciences companies use its software across more than 40 countries. Its product portfolio is organized into two suites: the Validation Lifecycle Suite (iVal™ for validation authoring and execution, iClean™ for digital cleaning validation, and iOps™ for digital operations and electronic logbooks) and the Process Lifecycle Suite (iCMC™ for Quality by Design process development and iCPV™ for continued process verification), all unified under the Smart GxP™ AI-enabled backbone. The VAL™ AI Validation Assistant adds generative-AI document generation, gap assessment, automated execution, and anomaly detection on top of the workflow platform, with claimed outcomes of up to 80% reduction in validation cycle time, 90% reduction in validation observations, and 30% cost reduction.

The company operates an enterprise field-sales GTM motion targeting large regulated life sciences buyers, supplemented by channel partnerships (notably Validator K.K. in Japan) and supported by an annual user conference (ValConnect), industry events (ISPE), webinars, and a content marketing program. Pricing is quote-based, sold as annual subscription licensing with implementation and support services, and revenue is not publicly disclosed. ValGenesis holds the first patent for paperless validation and aligns its platform with FDA, EMA, ICH Q9/Q12, GAMP 5, 21 CFR Part 11, and EU Annex 11; named customers include Roche, Bayer, GSK, Corden Pharma, Alexion, Strides, Philips, Stryker, Biocon, MilliporeSigma, Catalent, Dr. Reddy's, Illumina, Alkermes, Noven, Transcat, Theragent, and LOTTE Biologics. The company has raised approximately $40.4M in cumulative disclosed funding (including a $16M strategic financing in July 2025 from Bridge Bank and Morgan Stanley Expansion Capital), acquired Portugal-based 4Tune Engineering in June 2022, and recently appointed a new Chief Revenue Officer (Wayne Baker) to accelerate global sales execution.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSanta Clara, United States
HQ citystring
Santa Clara
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital validation lifecycle, GxP compliance software, computer system validation, cleaning validation software, continued process verification
Industry2 codes
PRIMARYHLAGAJAI
Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Software Publishers51321
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Life Sciences Validation Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software Platform Licensing and Subscription
TypeSubscription Recurring
Description

AI-enabled digital validation platform delivered as SaaS/subscription model. ValGenesis Smart GxP platform provides validation lifecycle management across Validation Lifecycle Suite and Process Lifecycle Suite products. Revenue derived from software licensing, implementation services, and ongoing support.

valgenesis.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others
Pricing details1 tier
1Enterprise subscription model - quote-based pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed. Pricing varies based on organizational size, deployment scope, and number of modules (iVal, iClean, iOps, iCMC, iCPV).

valgenesis.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 9 records shown
1Smart GxP™
Description

AI-enabled digital validation platform that seamlessly unifies development, commissioning, qualification, validation, and continued process verification.

valgenesis.com
+8 more records
Core offering1 text field

ValGenesis develops and sells the Smart GxP AI-enabled digital validation platform, unifying development, commissioning, qualification, validation, and continued process verification for the life sciences industry. The platform comprises the Validation Lifecycle Suite (iVal, iClean, iOps) and the Process Lifecycle Suite (iCMC, iCPV), sold as enterprise SaaS subscriptions to pharmaceutical, biotechnology, and medical device manufacturers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Validation cycle time reduced by up to 80%
+7 more records
Product overview1 text field

ValGenesis is an AI-powered digital validation and process lifecycle management company serving the life sciences industry. The company offers two main platform suites: the Validation Lifecycle Suite (comprising iVal, iClean, and iOps) and the Process Lifecycle Suite (comprising iCMC and iCPV), unified under the ValGenesis Smart GxP™ AI-enabled platform. The portfolio covers the full product lifecycle from drug process design through commercial performance, with products addressing commissioning, qualification, validation (CQV), computer software validation (CSV), cleaning validation, electronic logbooks, quality by design (QbD), and continued process verification (CPV). The company acquired Portugal-based 4Tune Engineering in 2022 to expand its manufacturing sciences capabilities.

Product and service1 record
1ValGenesis Smart GxP™ Platform
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-01
Description

Validator K.K. designated as Excellence Partner in Japan, responsible for implementing ValGenesis digital validation solutions across Japan's life sciences sector. The partnership extends digital validation capabilities to pharmaceutical and biotechnology companies, addressing regulatory compliance, labor shortages, and digitalization challenges in Japan. Validator K.K. resells Validation Lifecycle Suite and serves as referral partner for Process Lifecycle Suite.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-17
Description

South Korea-headquartered CDMO successfully implemented ValGenesis e-Logbook solution at satellite QC lab in Songdo. Implementation replaces paper-based logbooks with real-time digital forms featuring QR/barcode-based selection, offline data capture, and automated review workflows. Plans to extend platform across main laboratory and production facilities at Songdo Bio Campus and Syracuse, New York facility.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2022-06-06
Description

Portugal-based company specializing in manufacturing sciences and technologies. Acquisition completed June 6, 2022, aimed to expand ValGenesis' product portfolio, enhance validation lifecycle management systems, accelerate Pharma 4.0 strategy, and strengthen presence in European and LATAM markets.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Veeva's Vault QualityDocs and Vault Validation products provide cloud-based quality and validation document management for life sciences. Overlaps directly with ValGenesis's validation lifecycle and document-centric offerings, both targeting pharma/biotech GxP buyers.

TypeDirect peer
Description

MasterControl offers a unified quality and validation platform (Validation, QMS, EQMS) used by pharmaceutical and medical device manufacturers. Direct competitor in digital validation, especially for CSV and equipment qualification use cases.

TypeDirect peer
Description

Kneat's e-Validation platform digitizes commissioning, qualification, and validation lifecycles in life sciences. Closely comparable as a paperless validation SaaS targeting the same regulated pharma/biotech/medtech buyers.

TypeBroad incumbent
Description

TrackWise QMS and quality solutions from Sparta (Honeywell) serve pharma/life sciences including validation-related workflows. Competes broadly with ValGenesis on regulated quality and validation capabilities backed by a much larger parent.

TypeEmerging player
Description

Qualio provides cloud-native eQMS and validation tools for life sciences startups and mid-market pharma/medtech. Smaller-scale overlap with ValGenesis, particularly in CSV and document management for regulated quality systems.

TypeBroad incumbent
Description

LifeSphere platform (QMS, regulatory, safety) serving large pharma/biotech including validation-adjacent workflows. A broader regulated quality suite that overlaps with ValGenesis's GxP compliance buyers.

TypeEmerging player
Description

Provides AI-enabled quality and compliance management (eQMS) for pharma and medical device manufacturers. Emerging competitor in AI-augmented QMS with partial overlap to ValGenesis's VAL AI approach.

TypeEmerging player
Description

Quality management software purpose-built for medical device companies under ISO 13485 and FDA requirements. Adjacent overlap with ValGenesis's medical-device validation segment.

TypeEmerging player
Description

Next-gen QMS, EQMS, and quality management solution built on Salesforce targeting life sciences manufacturers. Competes with ValGenesis in regulated quality and validation documentation.

TypeBroad incumbent
Description

IQVIA's technology and services portfolio includes quality/compliance and lab digital solutions for life sciences. A broad incumbent with overlap to ValGenesis's pharma/medtech GxP buyers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration15 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ValGenesis

Life Sciences Validation Softwarevalgenesis.com

What ValGenesis does

ValGenesis is a privately held, AI-enabled digital validation lifecycle management company founded in 2005 and headquartered in the San Jose, California area. The company sells an integrated platform called Smart GxP™ to pharmaceutical, biotechnology, medical device, and contract development and manufacturing organizations (CDMOs), reporting that 30 of the top 50 global life sciences companies use its software across more than 40 countries. Its product portfolio is organized into two suites: the Validation Lifecycle Suite (iVal™ for validation authoring and execution, iClean™ for digital cleaning validation, and iOps™ for digital operations and electronic logbooks) and the Process Lifecycle Suite (iCMC™ for Quality by Design process development and iCPV™ for continued process verification), all unified under the Smart GxP™ AI-enabled backbone. The VAL™ AI Validation Assistant adds generative-AI document generation, gap assessment, automated execution, and anomaly detection on top of the workflow platform, with claimed outcomes of up to 80% reduction in validation cycle time, 90% reduction in validation observations, and 30% cost reduction.

The company operates an enterprise field-sales GTM motion targeting large regulated life sciences buyers, supplemented by channel partnerships (notably Validator K.K. in Japan) and supported by an annual user conference (ValConnect), industry events (ISPE), webinars, and a content marketing program. Pricing is quote-based, sold as annual subscription licensing with implementation and support services, and revenue is not publicly disclosed. ValGenesis holds the first patent for paperless validation and aligns its platform with FDA, EMA, ICH Q9/Q12, GAMP 5, 21 CFR Part 11, and EU Annex 11; named customers include Roche, Bayer, GSK, Corden Pharma, Alexion, Strides, Philips, Stryker, Biocon, MilliporeSigma, Catalent, Dr. Reddy's, Illumina, Alkermes, Noven, Transcat, Theragent, and LOTTE Biologics. The company has raised approximately $40.4M in cumulative disclosed funding (including a $16M strategic financing in July 2025 from Bridge Bank and Morgan Stanley Expansion Capital), acquired Portugal-based 4Tune Engineering in June 2022, and recently appointed a new Chief Revenue Officer (Wayne Baker) to accelerate global sales execution.

ValGenesis firmographics

Firmographics
Name
ValGenesis
Legal name
ValGenesis, Inc.
Website
https://valgenesis.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

ValGenesis industry classification

Industry
Product category
Life Sciences Validation Software
NAICS
Software Publishers (51321)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAI
Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Digital validation lifecycle
  • GxP compliance software
  • Computer system validation
  • Cleaning validation software
  • Continued process verification

Where ValGenesis is headquartered

Location

Headquarters

HQ city
Santa Clara
HQ country
United States
HQ region
North America

Offices2 records

Markets served

ValGenesis business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others

Revenue model

  1. Software Platform Licensing and Subscription: AI-enabled digital validation platform delivered as SaaS/subscription model. ValGenesis Smart GxP platform provides validation lifecycle management across Validation Lifecycle Suite and Process Lifecycle Suite products. Revenue derived from software licensing, implementation services, and ongoing support.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise subscription model - quote-based pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

ValGenesis product offering

Product offering

Core offering

ValGenesis develops and sells the Smart GxP AI-enabled digital validation platform, unifying development, commissioning, qualification, validation, and continued process verification for the life sciences industry. The platform comprises the Validation Lifecycle Suite (iVal, iClean, iOps) and the Process Lifecycle Suite (iCMC, iCPV), sold as enterprise SaaS subscriptions to pharmaceutical, biotechnology, and medical device manufacturers.

Product overview

ValGenesis is an AI-powered digital validation and process lifecycle management company serving the life sciences industry. The company offers two main platform suites: the Validation Lifecycle Suite (comprising iVal, iClean, and iOps) and the Process Lifecycle Suite (comprising iCMC and iCPV), unified under the ValGenesis Smart GxP™ AI-enabled platform. The portfolio covers the full product lifecycle from drug process design through commercial performance, with products addressing commissioning, qualification, validation (CQV), computer software validation (CSV), cleaning validation, electronic logbooks, quality by design (QbD), and continued process verification (CPV). The company acquired Portugal-based 4Tune Engineering in 2022 to expand its manufacturing sciences capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • Smart GxP™: AI-enabled digital validation platform that seamlessly unifies development, commissioning, qualification, validation, and continued process verification.
  • Validation Lifecycle Suite (VLS)
  • Process Lifecycle Suite (PLS)
  • iVal™
  • iClean™
  • iOps™
  • iCMC™
  • iCPV™
  • VAL™

Products and services

  • ValGenesis Smart GxP™ Platform

Quantifiable outcome

  • Validation cycle time reduced by up to 80%
  • +7 more outcomes

Companies that use ValGenesis

Customer profile

Named customers19 records

Segments4 records

Ideal customer profiles4 records

ValGenesis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration15 records

AI capability9 records

Feature8 records

ValGenesis partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and strategic.

  • Validator K.K.coreChannel Partner/ Reseller/ Distributor · 1 April 2026Validator K.K. designated as Excellence Partner in Japan, responsible for implementing ValGenesis digital validation solutions across Japan's life sciences sector. The partnership extends digital validation capabilities to pharmaceutical and biotechnology companies, addressing regulatory compliance, labor shortages, and digitalization challenges in Japan. Validator K.K. resells Validation Lifecycle Suite and serves as referral partner for Process Lifecycle Suite.
  • LOTTE BiologicscoreStrategic or Co-development Partner · 17 March 2026South Korea-headquartered CDMO successfully implemented ValGenesis e-Logbook solution at satellite QC lab in Songdo. Implementation replaces paper-based logbooks with real-time digital forms featuring QR/barcode-based selection, offline data capture, and automated review workflows. Plans to extend platform across main laboratory and production facilities at Songdo Bio Campus and Syracuse, New York facility.
  • 4Tune EngineeringstrategicStrategic or Co-development Partner · 6 June 2022Portugal-based company specializing in manufacturing sciences and technologies. Acquisition completed June 6, 2022, aimed to expand ValGenesis' product portfolio, enhance validation lifecycle management systems, accelerate Pharma 4.0 strategy, and strengthen presence in European and LATAM markets.

Scale indicators11 records

Recent moves6 records

Expansion highlights7 records

ValGenesis competitors and assessment

Company assessment

Direct peers

  • Veeva Systems: Veeva's Vault QualityDocs and Vault Validation products provide cloud-based quality and validation document management for life sciences. Overlaps directly with ValGenesis's validation lifecycle and document-centric offerings, both targeting pharma/biotech GxP buyers.
  • MasterControl: MasterControl offers a unified quality and validation platform (Validation, QMS, EQMS) used by pharmaceutical and medical device manufacturers. Direct competitor in digital validation, especially for CSV and equipment qualification use cases.
  • Kneat (now part of Stibo Systems): Kneat's e-Validation platform digitizes commissioning, qualification, and validation lifecycles in life sciences. Closely comparable as a paperless validation SaaS targeting the same regulated pharma/biotech/medtech buyers.

Broad incumbents

  • Sparta Systems (a Honeywell company): TrackWise QMS and quality solutions from Sparta (Honeywell) serve pharma/life sciences including validation-related workflows. Competes broadly with ValGenesis on regulated quality and validation capabilities backed by a much larger parent.
  • ArisGlobal: LifeSphere platform (QMS, regulatory, safety) serving large pharma/biotech including validation-adjacent workflows. A broader regulated quality suite that overlaps with ValGenesis's GxP compliance buyers.
  • IQVIA (Quality Compliance): IQVIA's technology and services portfolio includes quality/compliance and lab digital solutions for life sciences. A broad incumbent with overlap to ValGenesis's pharma/medtech GxP buyers.

Emerging players

  • Qualio: Qualio provides cloud-native eQMS and validation tools for life sciences startups and mid-market pharma/medtech. Smaller-scale overlap with ValGenesis, particularly in CSV and document management for regulated quality systems.
  • Dot Compliance: Provides AI-enabled quality and compliance management (eQMS) for pharma and medical device manufacturers. Emerging competitor in AI-augmented QMS with partial overlap to ValGenesis's VAL AI approach.
  • Greenlight Guru: Quality management software purpose-built for medical device companies under ISO 13485 and FDA requirements. Adjacent overlap with ValGenesis's medical-device validation segment.
  • ComplianceQuest: Next-gen QMS, EQMS, and quality management solution built on Salesforce targeting life sciences manufacturers. Competes with ValGenesis in regulated quality and validation documentation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

ValGenesis social profiles

Digital presence

ValGenesis compliance and trust

Trust signal

Compliance2 records

ValGenesis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ValGenesis leadership team

Management profile

Number of profiles

Profiles9 records

ValGenesis subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

ValGenesis funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ValGenesis M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ValGenesis

What does ValGenesis do?

ValGenesis develops and sells the Smart GxP AI-enabled digital validation platform, unifying development, commissioning, qualification, validation, and continued process verification for the life sciences industry. The platform comprises the Validation Lifecycle Suite (iVal, iClean, iOps) and the Process Lifecycle Suite (iCMC, iCPV), sold as enterprise SaaS subscriptions to pharmaceutical, biotechnology, and medical device manufacturers.

Is ValGenesis a public or private company?

ValGenesis is a private company. It is classified as venture growth investor backed and is currently operating.

When was ValGenesis founded?

ValGenesis was founded in 2005. It employs 501 to 1,000 people.

Where is ValGenesis based?

ValGenesis is headquartered in Santa Clara, United States, in the North America region.

How does ValGenesis make money?

One revenue line is on record: software Platform Licensing and Subscription.

Who are ValGenesis's main competitors?

Direct peers on record are Veeva Systems, MasterControl and Kneat (now part of Stibo Systems). Broad incumbents are Sparta Systems (a Honeywell company), ArisGlobal and IQVIA (Quality Compliance). Emerging players are Qualio, Dot Compliance, Greenlight Guru and ComplianceQuest.

Does ValGenesis have an API?

No public API is recorded for ValGenesis.

What industry is ValGenesis in?

ValGenesis's product category is Life Sciences Validation Software. Its primary akta.pro industry code is HLAGAJAI, Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs), with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 51321 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
techbuzzirelandEnterprise Validation Platform or Lighter CSV Tool? A Guide for Irish PharmaMatrix Validate is recommended for mid-size Irish pharma or biotech teams validating configured and custom GxP systems, offering enforced traceability and signed evidence. Enterprise platforms like Kneat and ValGenesis cover broader validation, while lighter CSV tools suit software-focused teams. The draft EU GMP Annex 11 revision emphasizes traceability, making Matrix Validate a strong fit.Analytics InsightBest Digital Validation Software in 2026: 7 Platforms Using Data and AIMatrix Validate is ranked the best digital validation software for 2026, with Kneat Gx and ValGenesis leading for enterprise-wide programs. The platforms use AI to draft test cases and find traceability gaps, but human approval is required. The EU's draft GMP Annex 22 sets expectations for AI in GxP work.citybizValGenesis Names David Horn President to Support Global Life Sciences GrowthValGenesis appointed David Horn as president, effective October 5, 2026, to support global expansion of its digital validation and AI platforms. Horn brings over two decades of experience, including as CFO of Seer Inc. and Morgan Stanley healthcare banker. He will work with CEO Siva Samy on strengthening the company's financial and operating foundation.FinancialContent Business PageValGenesis Appoints David Horn as PresidentValGenesis appointed David Horn as president, effective Oct. 5, 2026, to lead its Smart GxP and VAL AI platforms. Horn brings over two decades of experience, including as president and CFO of Seer and managing director at Morgan Stanley. He will work with CEO Siva Samy to support global growth.Business Wire BlogValGenesis to Bring Real-World AI-Assisted Validation Insights to KENX Europe 2026ValGenesis will present AI-assisted validation insights at KENX Europe 2026 in Amsterdam on Oct. 14–15, 2026. The company will share lessons from customer pilots and production deployments, with sessions on evaluating AI performance and building trust. ValGenesis is a Platinum Sponsor and will host an exhibit booth.YahooEugia Pharmaceuticals Goes Live with ValGenesis to Modernize CSVEugia Pharmaceuticals went live with ValGenesis to modernize computer system validation across its India sites. The deployment standardizes workflows and automates documentation, supporting compliance and operational efficiency. The company has filed over 200 abbreviated new drug applications.Business Wire BlogEugia Pharmaceuticals Goes Live with ValGenesis to Modernize CSVEugia Pharmaceuticals went live with ValGenesis to modernize computer system validation across its India operations. The deployment standardizes workflows and automates documentation, supporting compliance and growth. The company has filed over 200 abbreviated new drug applications.TalkMarketsValGenesis Appoints Wayne Baker as Chief Revenue Officer to Accelerate Global GrowthValGenesis appointed Wayne Baker as Chief Revenue Officer to lead its global sales organization, business development initiatives, and go-to-market execution in the life sciences technology sector. Baker brings extensive experience in enterprise software sales and revenue operations, and his appointment reflects ValGenesis' strategy to accelerate customer acquisition and expand its AI-powered digital validation platform among pharmaceutical, biotechnology, and medical device organizations. The company aims to strengthen strategic partnerships and support international growth as demand rises for AI-enabled validation solutions across regulated industries.